Non-invasive scanning for biomarkers after only 1 week may guide treatment for some patients with melanoma and avoid surgery in other patients. Imaging may help determine if the immunotherapeutic pembrolizumab (Keytruda) is helping patients with...
Preventive gastrectomy has lasting effects, and rising cancer incidence undercuts continued progress against mortality.
January is Cervical Cancer Awareness Month. Here's the latest on prevention, screening, and treatment.
In part 2 of our 2024 Experts Forecast, Robert A. Winn, MD, FAACR, discusses ways to achieve health equity.
Hiding serious illness can be a coping strategy, and cancer rates are on the rise among young people.
The blog rounds up the 2023 SABCS, which had 10,874 in-person and virtual registrants and featured cutting-edge research, thoughtful discussions, and plenty of networking.
Metastatic breast cancer remains incurable, but researchers’ understanding of the molecular features of the disease is leading to additional treatments.
Researchers are looking at ways to lessen and even prevent the debilitating chemotherapy-related side effect that causes numbness and pain in the hands and feet.
Study suggests people with advanced lung cancer who have a sustained response to immunotherapy can safely stop treatment after two years.
Study supports the use of immune checkpoint inhibitors in an understudied population.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More